Xibornol
From Wikipedia, the free encyclopedia
 |
|
|
Xibornol
|
|
| Systematic (IUPAC) name | |
| 4,5-dimethyl-2-[(1S,4R,6R)-1,7,7-trimethyl-6-bicyclo[2.2.1]heptanyl]phenol | |
| Identifiers | |
| CAS number | |
| ATC code | J01 |
| PubChem | |
| Chemical data | |
| Formula | C18H26O |
| Mol. mass | 258.398 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Xibornol is an antibiotic.
It is primarily administered to the throat.[1]
[edit] References
- ^ Cirri M, Mura P, Mora PC (2007). "Liquid spray formulations of xibornol by using self-microemulsifying drug delivery systems". Int J Pharm 340 (1-2): 84–91. doi:. PMID 17531411.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
||||||||||||||||||||
